Vitro, S.A.B. de C.V.
VITOF
$0.66
-$0.01-1.49%
OTC PK
| 09/30/2024 | 12/31/2023 | 09/30/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | 449.87% | -108.79% | -108.79% | -83.96% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | 449.87% | -108.79% | -108.79% | -83.96% |
| Cost of Revenue | -- | 794.75% | -116.50% | -116.50% | -91.63% |
| Gross Profit | -- | 178.29% | -82.08% | -82.07% | -56.15% |
| SG&A Expenses | -- | 206.35% | -92.06% | -92.07% | -70.76% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | 68.60% | 106.12% | 107.15% | 88.67% |
| Total Operating Expenses | -- | 544.21% | -111.83% | -111.82% | -87.60% |
| Operating Income | -- | 97.25% | -48.05% | -48.18% | 16.19% |
| Income Before Tax | -- | 33.95% | 598.47% | 600.24% | 438.80% |
| Income Tax Expenses | -- | -88.28% | -102.86% | -102.68% | -33.97% |
| Earnings from Continuing Operations | -- | 172.64% | 211.93% | 212.18% | 209.06% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -11.22% | 42.86% | 75.94% | 85.99% |
| Net Income | -- | 906.24% | 212.82% | 213.25% | 187.67% |
| EBIT | -- | 97.25% | -48.05% | -48.18% | 16.19% |
| EBITDA | -- | 49.48% | -21.90% | -21.96% | 5.06% |
| EPS Basic | -- | 734.26% | 221.65% | 221.76% | 197.03% |
| Normalized Basic EPS | -- | -4.91% | 142.82% | 138.03% | 233.69% |
| EPS Diluted | -- | 734.26% | 221.65% | 221.76% | 197.03% |
| Normalized Diluted EPS | -- | -4.91% | 142.82% | 138.03% | 233.69% |
| Average Basic Shares Outstanding | -- | -4.24% | -2.73% | -2.29% | 4.61% |
| Average Diluted Shares Outstanding | -- | -4.24% | -2.73% | -2.29% | 4.61% |
| Dividend Per Share | -- | -- | 200.94% | 200.94% | 200.94% |
| Payout Ratio | -- | -0.70% | 355.52% | 354.18% | 457.34% |